Author： Mogee M.E. Kolar R.G.
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.3, 1999-03, pp. : 291-305
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Patent citation analysis of Allergan pharmaceutical patents
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 10, 1998-10 ,pp. :
Access to resources
Recommend
An overview of CNS drug discovery at Eli Lilly and Company
By Paul S.M.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Olanzapine document leak rocks the boat for Eli Lilly
Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. :
Eli Lilly - DNA patenting through the ages
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. :